Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488). (6th April 2022) - Mahé, E.; Geldhof, A.; Jazra, M.; Bergmans, P.; Azzabi, A.; Seyger, M.M.B.